Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05521126 · ClinicalTrials.gov registry record
Micro-Doppler Radar: A Gold Standard Comparison
A clinical trial of Anterior Cruciate Ligament Injuries and Musculoskeletal Injury, sponsored by Milton S. Hershey Medical Center.
- Active
- Registry status
- 181
- Enrollment target
- 2
- Study locations
NCT05521126: Active study of Anterior Cruciate Ligament Injuries and Musculoskeletal Injury, sponsored by Milton S. Hershey Medical Center.
NCT05521126 is a study of Anterior Cruciate Ligament Injuries and Musculoskeletal Injury that is active but no longer recruiting, run by Milton S. Hershey Medical Center. The registered enrollment target is 181 participants, below the 316-participant average among 24 other Anterior Cruciate Ligament Injuries trials with a reported enrollment target (43% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05521126, a study of Anterior Cruciate Ligament Injuries and Musculoskeletal Injury, is active but no longer recruiting, sponsored by Milton S. Hershey Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 181 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to see if the study team can use micro-Doppler signal (MDS) technology to determine if someone has had an anterior cruciate ligament (ACL) reconstruction. The investigators will do this by comparing the movement data from a group of people who have had the surgery with a group who has not had the surgery to see if the micro-Doppler radar technology can accurately and predictably tell the difference.
Primary Outcome
The investigators hypothesize that MDS will differentiate subjects who have recovered from an ACL reconstruction from a control cohort with accuracy and predictability. Participants will perform drop jumps, sit to stand, and walk on a treadmill in the presence of the micro-Doppler radar. MDS will be obtained for the ACL group as well as control. The micro-Doppler signature projection algorithm (mD-SPA) will then be applied to the data sets showing what percentage of the MDS are successfully clas
Conditions Studied
Study Locations (2)
Pennsylvania
- Lebanon Valley College - Annville
- Pennsylvania State University College of Medicine - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2023-02-21 |
| Est. Completion | 2026-06 |
What the registry record for NCT05521126 still lists
NCT05521126 is an observational study that tracks outcomes without assigning an intervention. The registered 181 participants enrollment target is mid-sized for trials with a published cap, below the 316-participant average among 24 other Anterior Cruciate Ligament Injuries trials with a reported enrollment target (43% lower).
The record links to 2 conditions, with Anterior Cruciate Ligament Injuries appearing as the primary indexed condition, and to 0 interventions.
NCT05521126 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05521126 about?
NCT05521126 is a clinical study titled "Micro-Doppler Radar: A Gold Standard Comparison". The purpose of this study is to see if the study team can use micro-Doppler signal (MDS) technology to determine if someone has had an anterior cruciate ligament (ACL) reconstruction. The investigators will do this by comparing the movement data from a group of people who have had the surgery with a...
What is the current status of trial NCT05521126?
This trial is currently active not recruiting. The enrollment target is 181 participants. The study started on 2023-02-21. Estimated completion is 2026-06.
What conditions does trial NCT05521126 study?
This clinical trial studies the following conditions: Anterior Cruciate Ligament Injuries, Musculoskeletal Injury.
Who is sponsoring clinical trial NCT05521126?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05521126 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anterior Cruciate Ligament Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05521126's enrollment target sits among peer trials
181 5th of 24 higher than 20 of 24 other Anterior Cruciate Ligament Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anterior Cruciate Ligament Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IPACK on Early Pain Scores After ACL Reconstruction
RECRUITING · Phase 4
-
Anterior Cruciate Ligament Recovery With Virtual Psychological Intervention
RECRUITING · NA
-
Steps Towards Osteoarthritis Prevention
RECRUITING · NA
-
Gait Rehabilitation to Treat FastOA
RECRUITING · NA
-
Dynamic Muscular Electrical Stimulation Following Anterior Cruciate Ligament Reconstruction in Military Academy Cadets
RECRUITING · NA
-
PRP in ACLR to Prevent PTOA
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04578392 · 181 participants · NA
MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES)
- NCT05597891 · 181 participants · NA
Endovascular Engineering ENGULF Study
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI